ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Market Cap
TRY2.44bn
Enterprise Value
TRY2.24bn
Revenue
TRY529.83m

Annual income statement for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	422	410	468	344	530
Cost of Revenue
Gross Profit	373	359	402	275	335
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	71.3	70.3	31	231	457
Operating Profit	350	340	437	113	73
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	360	462	45.8	-211	-169
Provision for Income Taxes
Net Income After Taxes	316	443	-10.1	-197	-219
Minority Interest
Net Income Before Extraordinary Items
Net Income	293	433	-21.1	-197	-219
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	293	433	-21.1	-197	-219
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.67	2.86	-0.191	-0.864	-0.984
Dividends per Share